Expression of chemokine receptors in the different clinical forms of multiple sclerosis
about
Pathological expression of CXCL12 at the blood-brain barrier correlates with severity of multiple sclerosisInvolvement of beta-chemokines in the development of inflammatory demyelinationCirculating immune cells in multiple sclerosis.Systemic inflammation in progressive multiple sclerosis involves follicular T-helper, Th17- and activated B-cells and correlates with progression.Distinct roles for IP-10/CXCL10 in three animal models, Theiler's virus infection, EAE, and MHV infection, for multiple sclerosis: implication of differing roles for IP-10.Immunologic factors in primary progressive multiple sclerosis.CCR5 expression on monocytes and T cells: modulation by transmigration across the blood-brain barrier in vitro.Chemokines and chemokine receptors in multiple sclerosis. Potential targets for new therapies.G protein-coupled receptors as therapeutic targets for multiple sclerosis.Regulation of neuronal P53 activity by CXCR 4.Longitudinal analysis of activation markers on monocyte subsets during the development of simian immunodeficiency virus encephalitis.Circulating interleukin-15 and RANTES chemokine in MS patients: effect of treatment with methylprednisolone in patients with relapse.Tumor necrosis factor beta (TNF-β) NcoI polymorphism is associated with multiple sclerosis in Caucasian patients from Southern Brazil independently from HLA-DRB1.Interleukin-8 and RANTES levels in patients with relapsing-remitting multiple sclerosis (RR-MS) treated with cladribine.Variations in chemokine receptor and cytokine expression during pregnancy in multiple sclerosis patients
P2860
Q24642165-E56971C3-C469-40FC-9996-C576787C47F4Q24801279-4C0AA0CA-9044-4BE7-84D1-2CC1DC7FB397Q30242026-EECF6FCF-65EB-4918-9BD0-50B165B39CE6Q34613311-C81A6832-4313-4A0C-B4D0-EC47381B21F6Q35648177-F970B038-8753-4320-814B-34569267889FQ35818135-3D70A1C1-1933-4E11-8A93-80A1576707CBQ36497113-5F058C26-4796-49FD-836E-80821F9DB0F4Q36734084-4648C627-233B-4CFC-9141-BF7B16BFEE2FQ37112554-DDB60B67-54CE-42C0-8DCC-286D0FACC820Q41960358-E11CB414-AFA8-4770-A4DA-B35E62A7FDE6Q42228175-5941A55B-B4FD-4802-B755-C71C3BFB358FQ43287024-07F2F8A9-D445-444A-9B02-65382A69E8FFQ43568427-41D4F613-ABC7-4F8B-8AAA-41AE444C5C74Q44899043-39813705-6061-43C8-8528-12E433742C83Q57601989-36CB144A-C0BB-42A1-AA56-2F75EB658EB6
P2860
Expression of chemokine receptors in the different clinical forms of multiple sclerosis
description
im Oktober 2002 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 October 2002
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2002
@uk
name
Expression of chemokine receptors in the different clinical forms of multiple sclerosis
@en
Expression of chemokine receptors in the different clinical forms of multiple sclerosis
@nl
type
label
Expression of chemokine receptors in the different clinical forms of multiple sclerosis
@en
Expression of chemokine receptors in the different clinical forms of multiple sclerosis
@nl
prefLabel
Expression of chemokine receptors in the different clinical forms of multiple sclerosis
@en
Expression of chemokine receptors in the different clinical forms of multiple sclerosis
@nl
P2093
P2860
P50
P1476
Expression of chemokine receptors in the different clinical forms of multiple sclerosis
@en
P2093
I Sáez-Torres
P2860
P304
P356
10.1191/1352458502MS841OA
P577
2002-10-01T00:00:00Z